Related Experiment Video
Updated: Jun 14, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Protective effects of memantine and epicatechin on catechol-induced toxicity on Müller cells in vitro
Saffar Mansoor1, Navin Gupta, Georgia Luczy-Bachman
1Department of Ophthalmology, School of Medicine, University of California, Irvine, United States.
Abstract:
This study evaluates the toxic effects of catechol (a component from cigarette smoke) on Müller cells (MIO-M1) in vitro, and investigates the inhibitors memantine and epicatechin to determine if they can reverse the catechol toxic effects. MIO-M1 cells were exposed to varying concentrations of catechol with or without memantine or epicatechin. Cell viability (CV) was measured by a trypan blue dye-exclusion assay. Caspase-3/7 activity was measured by fluorochrome assay. The production of reactive oxygen/nitrogen species (ROS/RNS) was measured with 2',7'-dichlorodihydrofluorescein diacetate dye assay. Mitochondrial membrane potential (DeltaPsim) was measured using JC-1 assay. Intracellular ATP content was determined by the ATPLite kit. MIO-M1 cells showed significant decrease in cell viability, increased caspase-3/7 activity, elevated ROS/RNS levels, decreased DeltaPsim value, and decreased intracellular ATP content after exposure to catechol 150, 300, and 600 microM compared with control. Pre-treatment with memantine 10 microM or epicatechin 15 microM reversed loss of cell viability in catechol 150 microM-treated cultures (22.3%, p<0.01 and 17.8%, p<0.05), respectively. Similarly, pre-treatment with memantine 10 microM and epicatechin 15 microM prior to catechol resulted in decreased caspase-3/7 activities (77% and 64.2%, p<0.001), decreased ROS/RNS levels (82.3% and 79%, p<0.001), increased DeltaPsim value (76.4% and 72.2%, p<0.001), and increased ATP levels (46.6% and 40.4%, p<0.001) compared to 150 microM catechol-treated cultures. Catechol, a component of smoking, can diminish cell viability and mitochondrial function in MIO-M1 cells in vitro. However, memantine and epicatechin can partially reverse the cytotoxic effect of catechol. Their administration may reduce or prevent Müller cells degeneration in AMD or other retinal degenerative disorders.
Insights
Cigarette smoke component catechol harms Müller cells, impacting viability and mitochondrial function. Memantine and epicatechin offer partial protection against these toxic effects, potentially aiding retinal degenerative disorders.
Area of Science:
- Ophthalmology
- Cell Biology
- Toxicology
Background:
- Müller cells are crucial for retinal health and function.
- Catechol, a cigarette smoke component, is implicated in cellular damage.
- Retinal degenerative disorders like AMD involve Müller cell dysfunction.
Purpose of the Study:
- To evaluate the in vitro toxic effects of catechol on Müller cells (MIO-M1).
- To investigate the potential of memantine and epicatechin to reverse catechol-induced toxicity.
- To explore the mechanisms underlying catechol's cytotoxic effects on Müller cells.
Main Methods:
- MIO-M1 cells were exposed to varying catechol concentrations.
- Cell viability, caspase-3/7 activity, ROS/RNS production, mitochondrial membrane potential (DeltaPsim), and intracellular ATP content were measured.
- Effects of pre-treatment with memantine and epicatechin were assessed.
Main Results:
- Catechol exposure significantly decreased MIO-M1 cell viability and ATP levels, while increasing caspase-3/7 activity and ROS/RNS production.
- Catechol also reduced mitochondrial membrane potential.
- Memantine and epicatechin pre-treatment partially reversed catechol's detrimental effects on cell viability, caspase activity, ROS/RNS, DeltaPsim, and ATP levels.
Conclusions:
- Catechol exerts toxic effects on Müller cells, impairing viability and mitochondrial function.
- Memantine and epicatechin demonstrate protective potential against catechol-induced Müller cell damage.
- These findings suggest potential therapeutic strategies for retinal degenerative diseases involving Müller cell degeneration.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

